Zobrazeno 1 - 10
of 500
pro vyhledávání: '"J G Cairncross"'
Autor:
D. Livingstone, Martha Hughes, John Kelly, Shaghayegh Aslanpour, D. L. Trinh, Veronique G. LeBlanc, Marco A. Marra, Jennifer A. Chan, Michael D. Blough, J. G. Cairncross
Publikováno v:
SSRN Electronic Journal.
SummaryGlioblastomas (GBMs) are aggressive primary malignant brain tumors characterized by extensive levels of inter- and intra-tumor genetic and phenotypic heterogeneity. Patient-derived organoids (PDOs) have recently emerged as useful models to stu
Publikováno v:
Cell Proliferation. 49:698-709
Objectives Beryllium salts (here, beryllium sulphate) can produce a cytostatic effect in some cell types. The basis for this effect may include increased expression of proliferation inhibitors, reduced expression of proliferation promoters, or both.
Autor:
G., Reifenberger, J. G., Cairncross, D., Figarella-Branger, C., Hartmann, J. M., Kros, D. N., Louis, M., Snuderl, M. L., Suvà, M. J., Van Den Bent, S., Yip, H., Yokoo
Publikováno v:
WHO/IARC Classification of Tumours; 2021, Vol. 6, p28-38, 11p
Despite the discovery and widespread use of the chemotherapeutic drug temozolomide (TMZ), glioblastoma (GBM) remains a fatal cancer. TMZ, a DNA alkylating agent, provides a moderate survival benefit to patients whose tumours do not express the O6-met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6068812291fc2559572dc30bd0a9a568
https://europepmc.org/articles/PMC6216400/
https://europepmc.org/articles/PMC6216400/
Autor:
Blough, John Kelly, D. Livingstone, I Luthra, Martha Hughes, Veronique G. LeBlanc, J. G. Cairncross, D. L. Trinh, Marco A. Marra
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 45:S13-S14
Glioblastomas (GBMs) account for nearly half of all primary malignant brain tumours, and current therapies are often only marginally effective. Our understanding of the underlying biology of these tumours and the development of new therapies have bee
Autor:
D. Kozono, M. Nitta, O. Sampetrean, N. Kimberly, D. Kushwaha, D. Merzon, K. Ligon, S. Zhu, K. Zhu, T. H. Kim, C.-H. Kwon, O. Becher, H. Saya, C. C. Chen, L. K. Donovan, S. M. Birks, V. Bosak, G. J. Pilkington, P. Mao, J. Li, K. Joshi, B. Hu, S. Cheng, R. W. Sobol, I. Nakano, M. Li, J. S. Hale, J. T. Myers, A. Y. Huang, C. Gladson, A. A. Sloan, J. N. Rich, J. D. Lathia, P. E. Hall, J. Gallagher, Q. Wu, M. Venere, E. Levy, M. S. Rani, P. Huang, E. Bae, J. Selfridge, L. Cheng, H. Guvenc, R. E. McLendon, A. E. Sloan, H. Phillips, A. Lai, M. Bredel, S. Bao, A. Hjelmeland, M. Sinyuk, P. Sathyan, J. Hale, P. Zinn, C. T. Carson, U. Naik, S. Majumder, L. A. Song, A. Vasanji, N. Tenley, A. B. Hjelmeland, P. Peruzzi, A. Bronisz, E. Antonio Chiocca, J. A. Godlewski, O. A. Guryanova, X. Fang, H.-M. C. Christel, C. Benito, G. Zoltan, B. Aline, S. Tilman, B. Josephine, M. Carolin, S. Thomas, G. Violaine, A. Unterberg, V. Capilla-Gonzalez, H. Guerrero-Cazares, A. Cebrian-Silla, J. M. Garcia-Verdugo, A. Quinones-Hinojosa, J. Man, J. Shoemake, J. Rich, J. Yu, X. He, F. DiMeco, A. L. Vescovi, J. A. Heth, K. M. Muraszko, X. Fan, S. A. Nguyen, O. D. Stechishin, H. A. Luchman, J. J. Kelly, J. G. Cairncross, S. Weiss, Y. Kim, E. Kim, O. O. Guryanova, M. Hitomi, J. Lathia, D. Serwanski, J. Robert, J. Lee, A. Nishiyama, J. K. Liu, W. A. Flavahan, N. Fernandez, M. Wu, S. Das, E. Bazzoli, T. Pulvirenti, M. C. Oberstadt, F. Perna, W. Boyoung, N. Schultz, J. T. Huse, E. I. Fomchenko, F. Voza, V. Tabar, C. W. Brennan, L. M. DeAngelis, S. D. Nimer, E. C. Holland, M. Squatrito, Y.-H. Chen, D. H. Gutmann, S.-H. Kim, M. K. Lee, Y.-J. Chwae, B. C. Yoo, K.-H. Kim, A. Soeda, A. Hara, T. Iwama, D. M. Park, A. Golebiewska, S. Bougnaud, D. Stieber, N. H. Brons, L. Vallar, F. Hertel, R. Bjerkvig, S. P. Niclou, P. Hamerlik, R. Rasmussen, D. Fricova, B. Jiri, A. Schulte, A. Kathagen, S. Zapf, H. Meissner, H. S. Phillips, M. Westphal, K. Lamszus, M. Sanzey, S. K. Singh, A. Vartanian, J. Gumin, E. P. Sulman, F. F. Lang, G. Zadeh, N. S. Bayin, A. Dietrich, T. Abel, M. V. Chao, H.-R. Song, C. J. Buchholz, D. Placantonakis, M. Esencay, D. Zagzag, I. V. Balyasnikova, M. S. Prasol, S. D. Ferguson, A. U. Ahmed, Y. Han, M. S. Lesniak, M. E. Barish, C. E. Brown, K. Herrmann, S. Argalian, M. Gutova, Y. Tang, A. Annala, R. A. Moats, L. Y. Ghoda, K. S. Aboody, S. Gadani, J. Adkins, A. Vsanji, R. McLendon, A. Chenn, D. Park, C. Dictus, S. Friauf, N. A. Valous, N. Grabe, B. Muerle, A. W. Unterberg, C. C. Herold-Mende, H. K. Lee, S. Finniss, E. Buchris, A. Ziv-Av, S. Casacu, C. Xiang, K. Bobbit, S. A. Rempel, T. Mikkelsen, S. Slavin, C. Brodie, D.-H. Woo, Y. Oh, M. Kim, D.-H. Nam, Q. Li, S. Salas, C. Pendleton, O. Wijesekera, D. Chesler, J. Wang, C. Smith, A. Levchenko, Q. LaPlant, K. Pitter, A.-M. Bleau, K. Helmy, J. Werbeck, L. Barrett, F. Shimizu, R. Benezra, E. Holland, Q. Chu, E. Bar, B. Orr, C. G. Eberhart, R. S. Schmid, R. E. Bash, A. M. Werneke, K. K. White, C. R. Miller, F. Agasse, N. Jhaveri, F. M. Hofman, T. C. Chen, A. Natsume, T. Wakabayashi, Y. Kondo, N. Chang, E. Moon, R. Kanai, S. Yip, A. Kimura, S. Tanaka, E. Rheinbay, D. Cahill, W. Curry, G. Mohapatra, J. Iafrate, A. Chi, R. Martuza, S. Rabkin, H. Wakimoto, C. Cusulin, J. A. Frank, A. J. Annala
Publikováno v:
Neuro-Oncology. 14:vi142-vi152
Autor:
René-Olivier Mirimanoff, Charles J. Vecht, Peter A. Forsyth, J. G. Cairncross, Thierry Gorlia, Andrea O. Rossetti, Warren P. Mason, David R. Macdonald, Roger Stupp, Karl Belanger, Alba A. Brandes, M. J. van den Bent, Ulrich Bogdahn, Denis Lacombe, Michael Weller
Publikováno v:
Neurology, 77(12), 1156-1164. Lippincott Williams & Wilkins
Objective: This analysis was performed to assess whether antiepileptic drugs (AEDs) modulate the effectiveness of temozolomide radiochemotherapy in patients with newly diagnosed glioblastoma. Methods: The European Organization for Research and Treatm
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 45:S4-S4
Adult Glioblastomas (GBMs) remain one of the least curable brain cancers despite the discovery and use of DNA alkylating agent Temozolomide (TMZ). TMZ provides a moderate survival benefit to sensitive patients whose O6-methylguanine-methyltransferase
Autor:
Xu, Junfeng1,2,3,4,5 (AUTHOR), Lou, Xin1,2,3,4,5 (AUTHOR), Wang, Fei1,2,3,4,5 (AUTHOR), Zhang, Wuhu1,2,3,4,5 (AUTHOR), Xu, Xiaowu1,2,3,4,5 (AUTHOR), Ye, Zeng1,2,3,4,5 (AUTHOR), Zhuo, Qifeng1,2,3,4,5 (AUTHOR), Wang, Yan1,2,3,4,5 (AUTHOR), Jing, Desheng1,2,3,4,5 (AUTHOR), Fan, Guixiong1,2,3,4,5 (AUTHOR), Chen, Xuemin6 (AUTHOR), Zhang, Yue6 (AUTHOR), Zhou, Chenjie1,2,3,4,5 (AUTHOR), Chen, Jie1,2,3,4,5 (AUTHOR) chenjie@fudanpci.org, Qin, Yi1,2,3,4,5 (AUTHOR) qinyi@fudanpci.org, Yu, Xianjun1,2,3,4,5 (AUTHOR) yuxianjun@fudanpci.org, Ji, Shunrong1,2,3,4,5 (AUTHOR) jishunrong@fudanpci.org
Publikováno v:
Advanced Science. 9/18/2024, Vol. 11 Issue 35, p1-21. 21p.
Autor:
Bale, Ashwin A.1 (AUTHOR), Thammineni, Swaroop2 (AUTHOR), Bhargava, Rohit1,2,3,4,5 (AUTHOR) rxb@illinois.edu, Harley, Brendan1,3,5 (AUTHOR) bharley@illinois.edu
Publikováno v:
Advanced Nanobiomed Research. Sep2024, p1. 13p. 9 Illustrations.